Table 2 Leukocyte-related parameters of study participants by metabolic status.
Overweight/obesity | P value* | |||
---|---|---|---|---|
Participants | Metabolic normality | Metabolic abnormality | ||
All persons | n = 884 | n = 404 | n = 480 | |
Leukocyte, mean (SD), × 109/L | 5.62 (1.44) | 5.43 (1.54) | 5.79 (1.33) | < 0.01 |
Lymphocyte, mean (SD), × 109/L | 1.76 (0.77) | 1.70 (0.96) | 1.81 (0.56) | < 0.05 |
Monocyte, mean (SD), × 109/L | 0.33 (0.13) | 0.33 (0.12) | 0.33 (0.14) | 0.62 |
Neutrophil, mean (SD), × 109/L | 3.36 (1.04) | 3.24 (1.03) | 3.46 (1.04) | < 0.01 |
Eosinophil, mean (SD), × 109/L | 0.14 (0.13) | 0.13 (0.13) | 0.15 (0.13) | < 0.05 |
Basophil, mean (SD), × 109/L | 0.03 (0.02) | 0.03 (0.02) | 0.03 (0.02) | < 0.05 |
Men | n = 465 | n = 246 | n = 219 | |
Leukocyte, mean (SD), × 109/L | 5.68 (1.54) | 5.49 (1.66) | 5.90 (1.37) | < 0.01 |
Lymphocyte, mean (SD), × 109/L | 1.82 (0.92) | 1.66 (1.14) | 1.79 (0.56) | 0.13 |
Monocyte, mean (SD), × 109/L | 0.35 (0.15) | 0.35 (0.12) | 0.36 (0.17) | 0.42 |
Neutrophil, mean (SD), × 109/L | 3.42 (1.05) | 3.30 (1.02) | 3.55 (1.08) | < 0.05 |
Eosinophil, mean (SD), × 109/L | 0.15 (0.15) | 0.14 (0.15) | 0.17 (0.15) | 0.08 |
Basophil, mean (SD), × 109/L | 0.03 (0.02) | 0.03 (0.02) | 0.04 (0.02) | < 0.01 |
Women | n = 419 | n = 158 | n = 261 | |
Leukocyte, mean (SD), × 109/L | 5.57 (1.32) | 5.43 (1.54) | 5.79 (1.33) | < 0.01 |
Lymphocyte, mean (SD), × 109/L | 1.81 (0.56) | 1.76 (0.57) | 1.83 (0.56) | 0.20 |
Monocyte, mean (SD), × 109/L | 0.30 (0.10) | 0.29 (0.10) | 0.31 (0.09) | 0.15 |
Neutrophil, mean (SD), × 109/L | 3.30 (1.03) | 3.14 (1.04) | 3.40 (1.01) | < 0.05 |
Eosinophil, mean (SD), × 109/L | 0.13 (0.10) | 0.11 (0.09) | 0.14 (0.11) | < 0.01 |
Basophil, mean (SD), × 109/L | 0.03 (0.02) | 0.03 (0.02) | 0.03 (0.02) | 0.33 |